Integrative Medicine Conference
Please join us on Friday, May 9th, 2014 for a one-day continuing education conference for registered dietitians, naturopathic physicians and integrative medicine practitioners.
The conference will focus on genomics in relation to cancer prevention and treatment, diet and lifestyle.
The conference will be held at Cancer Treatment Centers of America at Western Regional Medical Center, 14200 W. Celebrate Life Way, Goodyear, AZ 85338. We are located off of Interstate 10 south of the Litchfield Park exit. Please utilize the complimentary valet parking when you arrive.
The conference has limited seating, so early registration is recommended. Pre-registration is now $150, and registration at the door is $175. Checks only. 5 CME are approved by Oregon Board of Naturopathic Medicine and 5 CEU's have been submitted for approval to CDR. For questions about the event, please contact Stephanie Paver at Stephanie.Paver@ctca-hope.com.
If you would like to stay the night, please contact our hotel partner TownePlace Suites Marriot.
For more details about this conference, please view our brochure and download the conference registration form.
Carol Ireton Jones, PhD, RDN, LD, CNSC, FASPEN, FAND
Personalized Medicine: Nutrigenomics and Weight Management
Dr. Ireton-Jones is a Registered Dietitian/Nutritionist Consultant in Private Practice. She specializes in GI nutrition, enteral and parenteral nutrition, and research. She is known for developing the Ireton-Jones equation, used nationally and internationally, to estimate energy requirements in hospitalized patients. She has lectured nationally and internationally on a variety of nutrition topics and has authored several books, book chapters and peer reviewed papers. Areas of expertise include energy expenditure, nutrition support, IBS, IBD, weight management and innovation in nutrition. She is managing partner for Professional Nutrition Therapists, LLC and Co-Founder and Chief Nutrition Officer for Utopia Food and Fitness in Plano, Texas.
Lise Alschuler, ND, FABNO
Preserving Intrinsic Apoptosis with Antioxidants for Cancer Prevention
Dr. Alschuler is a Naturopathic Doctor and graduate from Bastyr University with board certification in Naturopathic Oncology. She works as an independent consultant in the area of practitioner and consumer health education. She maintains a naturopathic oncology part-time practice out of Naturopathic Specialists, based in Scottsdale, AZ. Dr. Alschuler is the co-author of Definitive Guide to Cancer and Definitive Guide to Thriving after Cancer. She also co-hosts a radio show, Five To Thrive Live!
Glen Weiss, MD, MBA
Precision Medicine in Oncology
Dr. Glen Weiss serves as the Director of Clinical Research at Cancer Treatment Centers of America in Goodyear, AZ. Board certified in internal medicine and medical oncology, Dr. Weiss has completed numerous clinical trials with investigational agents, a few of which have received FDA approval. He also serves as a Clinical Associate Professor and Co-Head of the Lung Cancer Unit of the Cancer and Cell Biology Division at the Translational Genomics Research Institute (TGen) in Phoenix and Clinical Associate Professor at the University of Arizona College of Medicine-Phoenix. Dr. Weiss is also the Chief Medical Officer of the CRAB Clinical Trials Consortium, a position he was elected to in 2011.
Jessica A. Miller, PhD
Nutrimetabolomics and Cancer Prevention
Dr. Miller is an Assistant Research Professor in the Department of Nutritional Sciences at the University of Arizona and an Associate Member of the University of Arizona Cancer Center (UACC). Her research has focused on the bioactive food component limonene, a potential breast cancer chemopreventive found in citrus peel oil. Her research focus is moving into the area of metabolomics as a systemic approach to evaluate the effect of chemopreventive agents. Using metabolomics profiling with mass spectrometry-based techniques, she has investigated novel mechanisms and biomarkers of limonene activity after 4 weeks intervention in early stage breast cancer patients. Future work will focus on applying metabolomics to cancer prevention clinical trials in order to identify novel biomarkers of cancer risk and biomarkers in response to interventions.